Mass General Hospital, Est. 1811

Depression Clinical
and Research Program

  • Home
  • Clinical Care
  • Depression Information
    • About Depression
    • Alternate Treatments
      for Depression
    • Psychiatry in
      Primary Care
    • menu bottom image
  • Publications
    • Alternative Treatments for Depression
    • Treatment Resistant Depression
    • Major Depression and Other Disorders
    • Medication Side Effects
    • Minor Depression
    • Treatments for Depression
    • Psychotic Depression
    • Hormone/Biological/Genetic Research on Depression
    • Books
    • menu bottom image
  • Current Studies
    • Dual Diagnoses Studies
    • Studies for depressed patients not taking any antidepressants
    • Studies for depressed patients currently taking antidepressants
    • Non-treatment Studies
    • Studies for Smoking Cessation & Relapse Prevention
    • Other Studies
    • Psychotherapy Studies
    • menu bottom image
  • Links
  • Staff
    • Director
    • Associate Directors
    • Psychiatrists
    • Psychologists
    • Administrative Staff
    • Program Coordinator
    • Research Coordinators
    • Previous Staff
    • menu bottom image
  • Funding
    • The Goldstein Fund
    • The Judith Brown Caro Fund
    • Donations
    • menu bottom image
  • Contact
  • All Current Studies
  • Dual Diagnoses Studies
  • Studies for depressed patients not taking any antidepressants
  • Studies for depressed patients currently taking antidepressants
  • Non-treatment studies
  • Studies for Smoking Cessation & Relapse Prevention
  • Other Studies
  • Psychotherapy Studies

Studies for depressed patients not taking any antidepressants

If any of these studies interest you, please call us at 1-877-552-5837. (click study link for more details.)

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Sequential Trial of Ziprasidone as Monotherapy for Major Depressive Disorder

A Study of Omega 3-EPA vs. DHA Fatty Acids in the Treatment of Major Depression

A three-phase study designed to test the efficacy, tolerability and safety of the combination of Ziprasidone with the selective serotonin reuptake inhibitor (SSRI) Escitalopram for patients with Major Depressive Disorder (MDD) that do not sufficiently respond to treatment with Escitalopram


We initiate new studies regularly, so please contact us for additional information.

© 2008 The Depression Clinical and Research Program at Massachusetts General Hospital
50 Staniford Street, 4th Floor | Boston, MA 02114 | 1-877-552-5837

Directions